tag :: anticholesteremicagents:therapeuticuse

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

No matching posts.

⟨⟨
⟨
⟩
⟩⟩

publications (hide)3
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1Dichotomizing continuous variables in statistical analysis: a practice to avoid.
N. Dawson, and R. Weiss. Medical decision making : an international journal of the Society for Medical Decision Making, 32 (2): 225-6 (2012)6942<m:linebreak></m:linebreak>JID: 8109073; 0 (Anticholesteremic Agents); ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Categorització.
2 years ago by @jepcastel
show all tags
AnticholesteremicAgents
AnticholesteremicAgents:therapeuticuse
BiomedicalResearch
BiomedicalResearch:statistics&numericaldata
DataInterpretation
DecisionSupportTechniques
Diagnosis
Differential
EditorialPolicies
Humans
LongitudinalStudies
MetabolicSyndromeX
MetabolicSyndromeX:diagnosis
MetabolicSyndromeX:drugtherapy
MetabolicSyndromeX:epidemiology
NonlinearDynamics
PeriodicalsasTopic
Publishing
Statistical
AnticholesteremicAgentsAnticholesteremicAgents:therapeuticuseBiomedicalResearchBiomedicalResearch:statistics&numericaldataDataInterpretationDecisionSupportTechniquesDiagnosisDifferentialEditorialPoliciesHumansLongitudinalStudiesMetabolicSyndromeXMetabolicSyndromeX:diagnosisMetabolicSyndromeX:drugtherapyMetabolicSyndromeX:epidemiologyNonlinearDynamicsPeriodicalsasTopicPublishingStatistical
(0)
copydeleteadd this publication to your clipboard
1How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach.
J. Boissel. Fundamental & clinical pharmacology, 21 (2): 155-6 (April 2007)4215<m:linebreak></m:linebreak>PUBM: Print; JID: 8710411; 0 (Anticholesteremic Agents); 0 (Heptanoic Acids); 0 (Pyrroles); 110862-48-1 (atorvastatin); 57-88-5 (Cholesterol); CON: Fundam Clin Pharmacol. 2007 Apr;21(2):137-54. PMID: 17391286; ppublish;<m:linebreak></m:linebreak>Comparacions múltiples.
2 years ago by @jepcastel
show all tags
AnticholesteremicAgents
AnticholesteremicAgents:administration&dosage
AnticholesteremicAgents:therapeuticuse
Cholesterol
Cholesterol:blood
ClinicalProtocols
DataInterpretation
Dose-ResponseRelationship
Drug
HeptanoicAcids
HeptanoicAcids:administration&dosage
HeptanoicAcids:therapeuticuse
Humans
Models
Pyrroles
Pyrroles:administration&dosage
Pyrroles:therapeuticuse
RandomizedControlledTrialsasTopic:statistics
ResearchDesign
Statistical
RCT
AnticholesteremicAgentsAnticholesteremicAgents:administration&dosageAnticholesteremicAgents:therapeuticuseCholesterolCholesterol:bloodClinicalProtocolsDataInterpretationDose-ResponseRelationshipDrugHeptanoicAcidsHeptanoicAcids:administration&dosageHeptanoicAcids:therapeuticuseHumansModelsPyrrolesPyrroles:administration&dosagePyrroles:therapeuticuseRandomizedControlledTrialsasTopic:statisticsResearchDesignStatisticalRCT
(0)
copydeleteadd this publication to your clipboard
1Identifying and addressing safety signals in clinical trials.
T. Fleming. The New England journal of medicine, 359 (13): 1400-2 (September 2008)4904<m:linebreak></m:linebreak>JID: 0255562; 0 (Anticholesteremic Agents); 0 (Azetidines); 163222-33-1 (ezetimibe); 79902-63-9 (Simvastatin); CON: N Engl J Med. 2008 Sep 25;359(13):1343-56. PMID: 18765433; CON: N Engl J Med. 2008 Sep 25;359(13):1357-66. PMID: 18765432; 2008/09/03 aheadofprint; ppublish;.
2 years ago by @jepcastel
show all tags
AnticholesteremicAgents
AnticholesteremicAgents:adverseeffects
AnticholesteremicAgents:therapeuticuse
AorticValveStenosis
AorticValveStenosis:drugtherapy
Azetidines
Azetidines:adverseeffects
Azetidines:therapeuticuse
Combination
DiseaseProgression
DrugTherapy
Humans
Incidence
Neoplasms
Neoplasms:chemicallyinduced
Neoplasms:mortality
Risk
Simvastatin
Simvastatin:adverseeffects
Simvastatin:therapeuticuse
RCT
AnticholesteremicAgentsAnticholesteremicAgents:adverseeffectsAnticholesteremicAgents:therapeuticuseAorticValveStenosisAorticValveStenosis:drugtherapyAzetidinesAzetidines:adverseeffectsAzetidines:therapeuticuseCombinationDiseaseProgressionDrugTherapyHumansIncidenceNeoplasmsNeoplasms:chemicallyinducedNeoplasms:mortalityRiskSimvastatinSimvastatin:adverseeffectsSimvastatin:therapeuticuseRCT
(0)
copydeleteadd this publication to your clipboard

⟨⟨
⟨
1
⟩
⟩⟩

BibSonomy

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

publications (hide)3
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1Dichotomizing continuous variables in statistical analysis: a practice to avoid.

1How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach.

1Identifying and addressing safety signals in clinical trials.

browse

related tags

BibSonomy

bookmarks (hide) displayallbookmarks onlybookmarks per page5102050100 sort byadded attitle RSSBibTeXXML

publications (hide)3 displayallpublications onlypublications per page5102050100 sort byadded attitleauthorpublication dateentry typehelp for advanced sorting... RSSBibTeXRDFmore...

1Dichotomizing continuous variables in statistical analysis: a practice to avoid.

1How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach.

1Identifying and addressing safety signals in clinical trials.

browse

related tags

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

publications (hide)3
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...